Website profile

Biospace

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES V

  • 281articles · 30d
  • 5+ hour agolatest article
  • Aug 17, 2026earliest in window
  • 91%with images
  • 289avg words
articles per day
Categories
  • Economy, Business & Finance 160
  • Health & Wellness 129
  • Medical 128
  • Business & Industrial 117
  • Finance & Business 105
  • Health 59
  • Science & Technology 48
  • Science & Nature 33

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

BioSpace
biospace.com > press-releases > allarity-therapeutics-announces-strategic-capital-allocation-for-filing-of-spac-registration-statement

Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement

2+ day, 22+ hour ago   (373+ words) Allarity Acquisition Corp. may pursue an initial business combination in any industry, sector or geographic region. Jesper Hoiland, a current board member of Allarity and a former EVP and President of Novo Nordisk, will serve as Chairman of the board…...

BioSpace
biospace.com > press-releases > prime-therapeutics-names-manmohan-mahajan-chief-financial-officer

Prime Therapeutics names Manmohan Mahajan chief financial officer

3+ day, 9+ hour ago   (255+ words) EAGAN, Minn., Sept. 10, 2026 /PRNewswire/ -- Prime Therapeutics LLC (Prime) today announced that Manmohan Mahajan has been appointed as the company's chief financial officer (CFO), effective immediately. Mahajan brings more than 20 years of global finance and leadership experience across healthcare, pharmacy and…...

BioSpace
biospace.com > press-releases > innate-pharma-to-host-conference-call-and-webcast-on-september-17-for-first-half-2026-financial-results-and-business-update

Innate Pharma to Host Conference Call and Webcast on September 17 for First Half 2026 Financial Results and Business Update

4+ day, 35+ min ago   (133+ words) Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Thursday, September 17, 2026 at 2:00 p.m. CEST / 8:00 a.m. EDT, to provide a business update for the first…...

BioSpace
biospace.com > press-releases > retension-pharmaceuticals-appoints-leanne-bloedon-m-s-rd-as-evp-of-clinical-development-and-operations-and-kevin-schutz-pharmd-as-vp-regulatory-affairs

Retension Pharmaceuticals Appoints LeAnne Bloedon, M.S., RD, as EVP of Clinical Development and Operations, and Kevin Schutz, PharmD, as VP Regulatory Affairs

3+ day, 19+ hour ago   (140+ words) Statistics cookies help us to understand how visitors interact with websites by collecting and reporting information anonymously. Marketing cookies allow us to display more relevant ads that are engaging for our users and thereby, they are more valuable for publishers…...

BioSpace
biospace.com > press-releases > turn-therapeutics-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum

Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum

3+ day, 20+ hour ago   (194+ words) BioSpace Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted, localized therapies for inflammatory skin diseases, today announced that Bradley Burnam, Chief…...

BioSpace
biospace.com > press-releases > iqvia-announces-pricing-of-senior-notes-september-9-2026

IQVIA Announces Pricing of Senior Notes - September 9, 2026

4+ day, 6+ hour ago   (574+ words) BioSpace IQVIA Announces Pricing of Senior Notes - September 9, 2026 RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of $2,000,000,000 in aggregate principal amount of senior…...

Google News
biospace.com > press-releases > puma-biotechnology-to-present-at-h-c-wainwrights-28th-annual-global-investment-conference

Puma Biotechnology to Present at H.C. Wainwright???s 28th Annual Global Investment Conference

4+ day, 11+ hour ago   (391+ words) Puma Biotechnology to Present at H.C. Wainwright’s 28th Annual Global Investment Conference BioSpace Puma Biotechnology to Present at H.C. Wainwright’s 28th Annual Global Investment Conference LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman,…...

BioSpace
biospace.com > press-releases > electromed-inc-to-participate-in-the-h-c-wainwright-28th-annual-global-investment-conference-and-ld-micro-20th-annual-main-event

Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main Event

4+ day, 7+ hour ago   (195+ words) BioSpace Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main Event NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced their attendance…...

BioSpace
biospace.com > press-releases > latus-bio-appoints-donald-hayden-as-chairman-of-the-board-and-michael-maclean-as-independent-director-and-audit-committee-chair

Latus Bio Appoints Donald Hayden as Chairman of the Board and Michael MacLean as Independent Director and Audit Committee Chair

4+ day, 22+ hour ago   (626+ words) BioSpace Latus Bio Appoints Donald Hayden as Chairman of the Board and Michael MacLean as Independent Director and Audit Committee Chair Bristol Myers Squibb and seasoned biotechnology veteran Donald Hayden, M.B.A., appointed as Chairman of the Latus Board of Directors Former…...

BioSpace
biospace.com > press-releases > twist-bioscience-to-present-at-baird-2026-global-healthcare-conference

Twist Bioscience to Present at Baird 2026 Global Healthcare Conference

4+ day, 20+ hour ago   (265+ words) BioSpace Twist Bioscience to Present at Baird 2026 Global Healthcare Conference SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience,…...